Australia's Universal Biosensors hits 7-week high on partnership with Mayo Clinic

Universal Biosensors

11/11/2021 01:54

** Shares of Universal Biosensors  UBI.AX  rise as much as
5.7% to A$0.84, their highest since Sept. 24
    ** The medical diagnostics firm collaborates https://www.asx.com.au/asxpdf/20211111/pdf/452txbs14cmcm0.pdf
 with U.S.-based oncology research institute Mayo Clinic
Biopharma Diagnostics 
    ** Collaboration includes working on UBI's Tn antigen cancer
biosensor
    ** About 450,900 shares change hands, nearly double the
30-day average volume of nearly 228,200 shares
    ** Stock had risen 82.8% this year, as of last close

 (Reporting by Dhriti Garg in Bengaluru)
 ((dhriti.garg@thomsonreuters.com))